Recent Updates
Recently added Catalysts

Retractable Technologies, Inc.

RVPFDA catalysts, PDUFA dates & pipeline intelligence
$0.56
▼ 0 · -0.34%

Financials

Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Quarterly Cash
Unlock full RVP financials and dilution scoring
Quarter by quarter figures, cash trend and dilution risk.
Institutional-grade data · Cancel anytime
52W LOW $0.5552W HIGH $0.87
Volume
57.36 K
Value Traded
31.56 K
Short % Float
0.19%
Days to Cover
1.1
-1.29%Week
-4.36%1 Month
-21.03%3 Month
-17.49%6 Month
-92.78%5 Year
-87.04%All Time

Cash Data

Unlock RVP cash and runway
  • Monthly Burn
  • Burn Trend
  • Dilution Risk
  • SEC Filing

Key Stats

Market Cap
16.70 M
EPS (TTM)
-0.11
P/E Ratio
-
Ent. Value
13.91 M
Total Shares
29.92 M
Float Shares
12.21 M
Insiders
59.23%
Institutions
8.78%

Upcoming Catalysts

FDA decisions, readouts and PDUFA dates · scored by probability of approval

Catalyst Drug / Treatment Stage Prob. of Approval Description Drug Type Therapeutic Area Source
Unlock every RVP catalyst date and PoA score
Every FDA decision, readout and PDUFA date, with drug type, therapeutic area and a PoA score you can trade on.
Institutional-grade data · Cancel anytime
PoA blends historical approval base rates, trial design score and FDA review track record.

RVP Catalyst Timeline

Dated clinical, regulatory and corporate events for Retractable Technologies, Inc.

Unlock the full RVP catalyst timeline
Every PDUFA date, readout, approval and corporate move, tiered by market impact and updated daily.
Institutional-grade data · Cancel anytime

Past FDA Catalysts and PDUFA Decisions

How RVP actually traded into and out of each decision

Date Drug Catalyst Stage Reaction Event Move % Best Trade %
No matching catalysts
Unlock all RVP historical catalysts
Institutional-grade data · Cancel anytime
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision

Drug Pipeline Intelligence

No drug pipeline

Retractable Technologies, Inc. is a medical device company. The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.

Clinical Trial Results

Readouts, endpoints and source filings for every RVP program

Drug Name Indication Phase Date Trial Results SummaryTitleSource
Scroll for more · summaries link to the source press release
Unlock every RVP trial readout
Institutional-grade data · Cancel anytime

Inside Trades

Unlock RVP insider buying and selling
Monthly insider buys and sells against the stock price, with the insider sentiment reading.
Institutional-grade data · Cancel anytime
InsiderSideSharesPriceValueDate
SHAW THOMAS JDirector, Officer (PRESIDENT AND CEO), 10% OwnerBuy 5,731 15,831,222 held$0.77 11/14/2025
Unlock the full RVP insider trade log
Institutional-grade data · Cancel anytime

Hedge Fund 13F Activity

Fund % of Portfolio Current MV Shares Owned Activity
No hedge fund reported a 13F position in RVP for Q2 2026.
Unlock every fund holding RVP
Every 13F position with quarter over quarter share flow and average entry price.
Institutional-grade data · Cancel anytime
Unlock hedge fund flows in RVP
Shares held by hedge funds each quarter, and who bought or sold.

Ownership Trends

Sign in to see RVP ownership
Insider and institutional ownership, quarter by quarter.

RVP Short Interest

Shares sold short, counted twice a month.

0.19%
Short % of Float
of tradable shares sold short
22.9K
Shares Sold Short
-15.8% vs prior count
1.1 Low
Days to Cover
trading days of normal volume to buy every short share back
20.2K
Avg Daily Volume
the average used for days to cover
Unlock RVP short interest history
Two years of days to cover and shares sold short, with every count and its change.
Institutional-grade data · Cancel anytime

Options Data

Option Volume

Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg

Option Chain Statistics

ExpiryCall VolPut VolVol P/CCall OIPut OIOI P/CIV CallIV Call OI-WtdIV Call Vol-WtdIV PutIV Put OI-WtdIV Put Vol-Wtd
2026-11-20
Unlock RVP option chain statistics
Per-expiry call and put volume, open interest, put-call ratios and implied volatility.
Institutional-grade data · Cancel anytime

Real-Time Option Chain

CallsStrikePuts
LastVolOILastVolOI
No data available
Unlock the live RVP option chain
Live calls and puts by strike: last price, volume and open interest for every expiry.
Institutional-grade data · Cancel anytime

Calls vs Puts by Expiry

CallsPutsLog scale
Unlock RVP options analytics
Institutional-grade data · Cancel anytime

Competitive positioning

How RVP ranks across every disease it competes in

Competitive Position is a premium feature
See how RVP ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial

RVP News

RVP
Nov 16, 2026
RVPGeneral
▼ -0.3%today

Retractable Technologies, Inc. Results for the Periods Ended September 30, 2026

Retractable Technologies, Inc. reported total net sales of $14.1 million for Q3 2026, up from $10.1 million in the same period last year. However, the company also faced an operating loss of $4.1 million. For the first nine months of 2026, net sales reached $28.5 million, slightly down from $28.8 million in 2025.

Read more →
RVP
Sep 30, 2026
RVPGeneral

Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders

Retractable Technologies, Inc. has announced the declaration of dividends for its Series II and III Class B Convertible Preferred Stock. The total dividends amount to $57,611.25, with $39,050.00 allocated to Series II and $18,561.25 to Series III. These dividends will be paid on October 22, 2026, covering the period from July 1, 2026, to September 30, 2026.

Read more →
RVP
Sep 3, 2026
RVPGeneral

Retractable Technologies, Inc. Supports Senator Blackburn’s ONSHORE Manufacturing Act

Retractable Technologies, Inc. has expressed its support for Senator Marsha Blackburn's ONSHORE Manufacturing Act. This legislation aims to enhance domestic production of essential medical supplies by offering tax incentives for U.S. manufacturing. The act is expected to stimulate investments in advanced manufacturing equipment and facility upgrades.

Read more →
RVP
Aug 14, 2026
RVPGeneral

Retractable Technologies, Inc. Results for the Periods Ended June 30, 2026

Retractable Technologies, Inc. reported a decline in net sales for the second quarter of 2026, totaling $7.2 million, down from $10.4 million in the same period last year. The company also experienced an operating loss of $5.1 million, consistent with the previous year. For the first half of 2026, net sales were $14.4 million, compared to $18.7 million in 2025, indicating ongoing financial challenges.

Read more →
RVP
May 15, 2026
RVPGeneral
▼ -7.3%on this news

RETRACTABLE TECHNOLOGIES, INC. RESULTS FOR THE PERIOD ENDED MARCH 31, 2026

Retractable Technologies, Inc. reported total net sales of $7.2 million for the first quarter of 2026, a decline from $8.3 million in the same period last year. The company experienced an operating loss of $6.2 million compared to $4.7 million the previous year, influenced by increased operating expenses and a significant reduction in domestic sales. Despite a rise in international sales driven by EasyPoint needle sales, overall revenues fell due to decreased selling prices and a negative gross margin. Additionally, the workforce was reduced by approximately 16% to save costs.

Read more →
RVP
Apr 9, 2026
RVPGeneral
▼ -6.7%on this news

Retractable Technologies, Inc. Announces Workforce Reduction

Retractable Technologies, Inc. has announced a 16% workforce reduction aimed at saving approximately $2.2 million in annual costs. This decision is part of the company's strategy to enhance domestic production and reduce reliance on imports from China, particularly in light of tariff impacts. While the move is expected to improve efficiency, it also involves one-time separation payments for affected employees.

Read more →
RVP
Apr 9, 2026
RVPGeneral
▲ +5.5%on this newsshared move

RETRACTABLE TECHNOLOGIES, INC. ANNOUNCES

Retractable Technologies, Inc. has announced a significant workforce reduction of about 16%, aimed at saving approximately $2.2 million in annual costs. This move is part of the company's strategy to enhance domestic manufacturing capabilities and mitigate reliance on Chinese imports, largely influenced by tariffs. Although the reduction will help cut costs, it also brings about one-time separation payments to affected workers and continues the company's dependence on imports for certain products.

Read more →
RVP
Mar 27, 2026
RVPGeneral

RETRACTABLE TECHNOLOGIES, INC. REPORTS

Retractable Technologies, Inc. reported a 15.8% increase in revenues for the year 2025, reaching approximately $38.3 million. Significant growth in international sales, particularly for EasyPoint needles, contributed to this rise. However, the company also faced high operating costs and incurred losses from operations totaling $21.2 million, similar to the previous year’s results. The ongoing impact of tariffs, particularly a 120% rate on imported products from China, creates uncertainty for future operations and financial stability.

Read more →
RVP
Dec 30, 2025
RVPGeneral

RETRACTABLE TECHNOLOGIES, INC. DECLARES DIVIDENDS TO SERIES II AND III CLASS B PREFERRED STOCK SHAREHOLDERS

Retractable Technologies, Inc. has announced the declaration of dividends for its Series II and III Class B Preferred Stock shareholders, amounting to $39,050.00 and $18,561.25 respectively. These dividends, accruing at $1.00 per share per annum, cover the period from October 1 to December 31, 2025, and are set to be paid on January 20, 2026, to shareholders recorded by January 10, 2026. This announcement highlights the company's ongoing commitment to providing returns to its investors amidst its operational initiatives in safety medical products.

Read more →
RVP
Nov 14, 2025
RVPGeneral

Retractable Technologies, Inc. Receives Innovative Technology Designation from Vizient for EasyPoint Blood Collection Tube Holder with Needle

Retractable Technologies, Inc. has announced that its EasyPoint Blood Collection Tube Holder with Needle has received an Innovative Technology designation from Vizient. This recognition highlights the product's potential to enhance patient and healthcare worker safety by reducing needlestick injuries. The device is designed for ease of use and efficiency, demonstrating the company's commitment to innovation in healthcare.

Read more →
RVP
Nov 14, 2025
RVPGeneral

RETRACTABLE TECHNOLOGIES, INC. RESULTS FOR THE PERIODS ENDED SEPTEMBER 30, 2025

Retractable Technologies, Inc. reported total net sales of $10.1 million and an operating loss of $3.7 million for Q3 2025, reflecting a modest improvement compared to the prior year's results. The company continues to face challenges due to high tariffs on imported products, which have materially affected its operational costs. Despite the difficulties, there has been a reduction in overall operating losses, and international revenues saw an increase. Moving forward, efforts to shift production to domestic facilities are ongoing to mitigate tariff impacts.

Read more →
RVP
Sep 10, 2025
RVPGeneral

Retractable Technologies Welcomes Congressional Leaders to Highlight Texas Innovation and U.S. Supply Chain Readiness

Retractable Technologies, Inc. hosted Texas congressional leaders to showcase its efforts in enhancing domestic manufacturing of medical devices. The visit emphasized the company's commitment to protecting healthcare workers and strengthening the U.S. supply chain, with over $138 million invested since the COVID-19 pandemic. CEO Thomas Shaw highlighted the importance of collaboration between policy and industry.

Read more →
RVP
Aug 14, 2025
RVPGeneral

RETRACTABLE TECHNOLOGIES, INC. RESULTS FOR THE PERIODS ENDED JUNE 30, 2025

Retractable Technologies, Inc. reported total net sales of $10.4 million for Q2 2025, up from $6.0 million in Q2 2024, but also recorded a higher operating loss of $5.1 million. Tariffs imposed on imports from China continue to heavily affect the company's financial performance, prompting a shift toward more U.S.-based production. Moreover, sales of the EasyPoint needle contributed positively to revenues, but a decrease in average selling price due to product mix changes was noted. The company also reported a net loss for the first six months of the year totaling $10.6 million, including an unrealized loss on investments of $5.6 million, although they received a $1.9 million settlement in the second quarter.

Read more →
RVP
Jul 23, 2025
RVPGeneral

RETRACTABLE TECHNOLOGIES, INC. ANNOUNCES REDUCTION IN ITS MANUFACTURING WORKFORCE

Retractable Technologies, Inc. has announced a 12.4% reduction in its manufacturing workforce, aiming to save about $1.6 million in annual costs. This move is part of the company's strategy to enhance domestic production while facing challenges posed by tariffs on imported products from China. The decision also involves one-time separation payments to affected workers, highlighting the company's need to balance costs with operational efficiency. The future remains uncertain regarding U.S. trade policy and its effects on the company's import capabilities.

Read more →
RVP
May 15, 2025
RVPGeneral

RETRACTABLE TECHNOLOGIES, INC. RESULTS FOR THE PERIOD ENDED MARCH 31, 2025

Retractable Technologies, Inc. reported total net sales of $8.3 million for Q1 2025, marking an increase from $7.6 million in Q1 2024. However, the company experienced a higher operating loss of $4.7 million, attributed to rising tariffs and increased production costs, which also contributed to a significant unrealized loss on investments. Domestic sales represented a strong 89.6% of total revenues, with unit sales up by 18.9%, although average selling prices faced pressure due to shifts in product mix. The ongoing challenges from tariffs are anticipated to impact future profitability.

Read more →
RVP
Apr 10, 2025
RVPGeneral

RETRACTABLE TECHNOLOGIES, INC. ANNOUNCES REDUCTION IN WORKFORCE

Retractable Technologies, Inc. has announced a 7% reduction in its workforce, aiming to save around $1.6 million in annual wages and benefits. The company plans to enhance its U.S. manufacturing capabilities, decreasing reliance on products produced in China due to tariffs. While this move may provide some long-term financial benefits, the company faces immediate costs associated with separation payments and uncertainty related to future trade policies.

Read more →

About Retractable Technologies, Inc.

Little Elm, TX 201 employees retractable.com
Headquarters511 LOBO LANE, LITTLE ELM, TX, 75068-0009
Founded04-05-2001
BIOPHARMAWATCH ELITE
Trade the next RVP catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $24/mo billed annually.
Cancel anytime